Sort   by:  
 Page size 
UnknownSelective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma.
Not available
S-EPMC6905485 | biostudies-literature
UnknownReducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement.
Not available
S-EPMC11969261 | biostudies-literature
UnknownIntegrative analysis of drug response and clinical outcome in acute myeloid leukemia.
Not available
S-EPMC9378589 | biostudies-literature
UnknownCancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
Not available
S-EPMC7049229 | biostudies-literature
UnknownFour consecutive yearly point-prevalence studies in Wales indicate lack of improvement in sepsis care on the wards.
Not available
S-EPMC8355110 | biostudies-literature
UnknownA Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.
Not available
S-EPMC9018520 | biostudies-literature
UnknownEvaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.
Not available
S-EPMC10357473 | biostudies-literature
UnknownEvidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.
Not available
S-EPMC10424812 | biostudies-literature
UnknownTrans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.
Not available
S-EPMC8148035 | biostudies-literature
UnknownGenome-wide association studies identify four ER negative-specific breast cancer risk loci.
Not available
S-EPMC3771695 | biostudies-literature
Sort   by:  
 Page size